Monsanto Co. has agreed to pay the University of California more than $100 million to settle the school's claim that the biotechnology company infringed on its patent related to a hormone that makes cows produce more milk. At issue is the genetically engineered bovine somatotropin hormone, sold under the brand name Posilac. Monsanto says injections of the hormone helps dairy cows produce 10 percent to 15 percent more milk.
February 28, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Monsanto Co. agreed to pay the University of California more than $100 million to settle the school’s claim that the biotechnology company infringed on its patent related to a hormone that makes cows produce more milk.
The university’s Board of Regents sued Monsanto for patent infringement in 2004, and the case was scheduled to go to trial Monday.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
